• InspireMD to Participate in Upcoming November Investor Conferences

    Source: Nasdaq GlobeNewswire / 02 Nov 2023 07:00:01   America/Chicago

    TEL AVIV, Israel and MIAMI, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery disease and prevention of stroke, today announced that the Marvin Slosman, Chief Executive Officer, will participate in three upcoming investor conferences in November:

    Wolfe Research Healthcare Conference

    Wednesday, November 15, 2023

    Fireside chat: 12:30pm ET

    Canaccord Genuity MedTech, Diagnostics, Digital Health & Services Forum

    Thursday, November 16, 2023

    Investor one-on-one meetings only

    Piper 35th Annual Healthcare Conference

    Wednesday, November 29, 2023

    Fireside chat: 8:00am ET

    A live webcast of the presentations will be available in the News and Events section of the Company’s website at www.inspiremd.com/en/events/. Replays will be available on the website for 30 days.

    About InspireMD, Inc.

    InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free, long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.

    We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

    Investor Contacts:

    Craig Shore
    Chief Financial Officer
    InspireMD, Inc.
    888-776-6804
    craigs@inspiremd.com

    Chuck Padala, Managing Director
    LifeSci Advisors
    646-627-8390
    chuck@lifesciadvisors.com

    investor-relations@inspiremd.com


    Primary Logo

Share on,